Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nature Wood Group ADR | NWGL | Nov 27, 2024 | 1.41 | -0.35 |
Natures Miracle Holding | NMHI | Nov 27, 2024 | 2.81 | +16.12 |
Natures Sunshine Products | NATR | Nov 27, 2024 | 16.15 | -1.94 |
Natuzzi ADR | NTZ | Nov 27, 2024 | 4.70 | -3.29 |
NatWest ADR | NWG | Nov 27, 2024 | 10.03 | +1.01 |
Nauticus Robotics | KITT | Nov 27, 2024 | 1.12 | +9.80 |
Nautilus Biotechnology | NAUT | Nov 27, 2024 | 2.30 | +2.68 |
Navidea Biopharmaceuticals | NAVB | Nov 27, 2024 | 0.00 | 0.00 |
Navient | NAVI | Nov 27, 2024 | 15.32 | +0.46 |
Navigator Holdings | NVGS | Nov 27, 2024 | 15.72 | +0.51 |
Navios Maritime Partners LP Unit | NMM | Nov 27, 2024 | 47.91 | +0.67 |
Navitas Semiconductor | NVTS | Nov 27, 2024 | 2.46 | -3.53 |
Naya Biosciences | NAYA | Nov 27, 2024 | 0.94 | 0.00 |
Nayax | NYAX | Nov 27, 2024 | 29.74 | +2.16 |
NB Bancorp | NBBK | Nov 27, 2024 | 20.18 | -0.54 |
NBT Bancorp | NBTB | Nov 27, 2024 | 50.08 | -0.08 |
Ncino | NCNO | Nov 27, 2024 | 41.88 | -0.88 |
NCR | VYX | Nov 27, 2024 | 14.49 | +0.98 |
NCR Atleos When Issued | NATL | Nov 27, 2024 | 32.68 | +1.59 |
NCS Multistage | NCSM | Nov 27, 2024 | 22.56 | -0.31 |
Nebius Group | NBIS | Nov 27, 2024 | 21.43 | 0.00 |
Nektar Therapeutics | NKTR | Nov 27, 2024 | 1.13 | +5.61 |
Nelnet | NNI | Nov 27, 2024 | 108.76 | -0.23 |
Neogen | NEOG | Nov 27, 2024 | 14.14 | -0.21 |
NeoGenomics | NEO | Nov 27, 2024 | 17.74 | +3.26 |
Neonode | NEON | Nov 27, 2024 | 7.85 | +1.29 |
NeoVolta | NEOV | Nov 27, 2024 | 4.96 | -8.66 |
Nephros | NEPH | Nov 27, 2024 | 1.51 | -3.21 |
NerdWallet A | NRDS | Nov 27, 2024 | 14.23 | +2.60 |
Nerdy A | NRDY | Nov 27, 2024 | 1.38 | -6.12 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.